PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
NVZMY vs. MAERSK-B.CO
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

NVZMY vs. MAERSK-B.CO

Last updated Apr 3, 2026

Compare and contrast key facts about Novozymes AS (NVZMY) and A.P. Møller - Mærsk A/S (MAERSK-B.CO).

Performance

NVZMY vs. MAERSK-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Novozymes AS (NVZMY) and A.P. Møller - Mærsk A/S (MAERSK-B.CO). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NVZMY vs. MAERSK-B.CO - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
NVZMY
Novozymes AS		-4.92%14.29%3.97%12.42%-38.46%46.93%18.10%10.28%-20.91%69.59%
MAERSK-B.CO
A.P. Møller - Mærsk A/S		10.87%52.35%1.57%12.93%-29.32%63.35%61.04%34.12%-26.72%11.19%
Different Trading Currencies

NVZMY is traded in USD, while MAERSK-B.CO is traded in DKK. To make them comparable, the MAERSK-B.CO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, NVZMY achieves a -4.92% return, which is significantly lower than MAERSK-B.CO's 10.87% return. Over the past 10 years, NVZMY has underperformed MAERSK-B.CO with an annualized return of 4.36%, while MAERSK-B.CO has yielded a comparatively higher 17.65% annualized return.

NVZMY

1D
-0.52%
1M
6.03%
YTD
-4.92%
6M
-1.06%
1Y
4.63%
3Y*
7.56%
5Y*
0.19%
10Y*
4.36%

MAERSK-B.CO

1D
-0.08%
1M
-5.36%
YTD
10.87%
6M
29.05%
1Y
48.21%
3Y*
19.49%
5Y*
16.06%
10Y*
17.65%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Novozymes AS

A.P. Møller - Mærsk A/S

Often compared with NVZMY:
NVZMY vs. DSV.CONVZMY vs. MAERSK-A.CONVZMY vs. ZEAL.CONVZMY vs. NVONVZMY vs. NOVO-B.CONVZMY vs. GMABNVZMY vs. SNY
Often compared with MAERSK-B.CO:
MAERSK-B.CO vs. SBMAERSK-B.CO vs. DSV.COMAERSK-B.CO vs. KHNGYMAERSK-B.CO vs. VWDRYMAERSK-B.CO vs. DANSKE.COMAERSK-B.CO vs. UPS

Return for Risk

NVZMY vs. MAERSK-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
NVZMY
NVZMY Risk / Return Rank: 4242
Overall Rank
NVZMY Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
NVZMY Sortino Ratio Rank: 3939
Sortino Ratio Rank
NVZMY Omega Ratio Rank: 3939
Omega Ratio Rank
NVZMY Calmar Ratio Rank: 4343
Calmar Ratio Rank
NVZMY Martin Ratio Rank: 4343
Martin Ratio Rank
MAERSK-B.CO
MAERSK-B.CO Risk / Return Rank: 6868
Overall Rank
MAERSK-B.CO Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
MAERSK-B.CO Sortino Ratio Rank: 6565
Sortino Ratio Rank
MAERSK-B.CO Omega Ratio Rank: 6464
Omega Ratio Rank
MAERSK-B.CO Calmar Ratio Rank: 6868
Calmar Ratio Rank
MAERSK-B.CO Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVZMY vs. MAERSK-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Novozymes AS (NVZMY) and A.P. Møller - Mærsk A/S (MAERSK-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

NVZMYMAERSK-B.CODifference

Sharpe ratio

Return per unit of total volatility

0.17

1.14

-0.97

Sortino ratio

Return per unit of downside risk

0.44

1.70

-1.26

Omega ratio

Gain probability vs. loss probability

1.06

1.22

-0.17

Calmar ratio

Return relative to maximum drawdown

0.18

1.85

-1.67

Martin ratio

Return relative to average drawdown

0.36

5.41

-5.05

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NVZMY vs. MAERSK-B.CO - Sharpe Ratio Comparison

The current NVZMY Sharpe Ratio is 0.17, which is lower than the MAERSK-B.CO Sharpe Ratio of 1.14. The chart below compares the historical Sharpe Ratios of NVZMY and MAERSK-B.CO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading graphics...

Sharpe Ratios by Period

NVZMYMAERSK-B.CODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.17

1.14

-0.97

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.01

0.39

-0.38

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.16

0.45

-0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

0.20

-0.28

Correlation

The correlation between NVZMY and MAERSK-B.CO is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NVZMY vs. MAERSK-B.CO - Dividend Comparison

NVZMY's dividend yield for the trailing twelve months is around 2.73%, less than MAERSK-B.CO's 3.00% yield.

TTM20252024202320222021202020192018201720162015
NVZMY
Novozymes AS		2.73%1.51%1.03%2.68%1.68%0.69%0.91%1.03%1.10%1.64%0.95%0.60%
MAERSK-B.CO
A.P. Møller - Mærsk A/S		3.00%7.65%4.33%36.81%16.63%1.46%1.15%1.62%2.18%1.65%3.17%26.18%

Drawdowns

NVZMY vs. MAERSK-B.CO - Drawdown Comparison

The maximum NVZMY drawdown since its inception was -86.29%, which is greater than MAERSK-B.CO's maximum drawdown of -72.93%. Use the drawdown chart below to compare losses from any high point for NVZMY and MAERSK-B.CO.

Loading graphics...

Drawdown Indicators

NVZMYMAERSK-B.CODifference

Max Drawdown

Largest peak-to-trough decline

-86.29%

-69.40%

-16.89%

Max Drawdown (1Y)

Largest decline over 1 year

-29.64%

-18.09%

-11.55%

Max Drawdown (5Y)

Largest decline over 5 years

-51.86%

-43.52%

-8.34%

Max Drawdown (10Y)

Largest decline over 10 years

-51.86%

-57.49%

+5.63%

Current Drawdown

Current decline from peak

-59.08%

-11.53%

-47.55%

Average Drawdown

Average peak-to-trough decline

-57.40%

-23.04%

-34.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.04%

8.67%

+6.37%

Volatility

NVZMY vs. MAERSK-B.CO - Volatility Comparison

The current volatility for Novozymes AS (NVZMY) is 7.88%, while A.P. Møller - Mærsk A/S (MAERSK-B.CO) has a volatility of 11.29%. This indicates that NVZMY experiences smaller price fluctuations and is considered to be less risky than MAERSK-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading graphics...

Volatility by Period

NVZMYMAERSK-B.CODifference

Volatility (1M)

Calculated over the trailing 1-month period

7.88%

11.29%

-3.41%

Volatility (6M)

Calculated over the trailing 6-month period

18.90%

25.68%

-6.78%

Volatility (1Y)

Calculated over the trailing 1-year period

27.16%

41.36%

-14.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.78%

41.80%

-14.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.19%

39.83%

-12.64%

Financials

NVZMY vs. MAERSK-B.CO - Financials Comparison

This section allows you to compare key financial metrics between Novozymes AS and A.P. Møller - Mærsk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

Please note, different currencies. NVZMY values in USD, MAERSK-B.CO values in DKK